| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0735-1097(85)80174-1 |
| P698 | PubMed publication ID | 3160756 |
| P2093 | author name string | D F Phillips | |
| N B Ratliff | |||
| G E Austin | |||
| J Hollman | |||
| S Tabei | |||
| P2860 | cites work | Transluminal coronary angioplasty and early restenosis. Fibrocellular occlusion after wall laceration | Q36743612 |
| Results from coronary angioplasty and implications for the future | Q41460880 | ||
| Morphology after transluminal angioplasty in human beings | Q42092108 | ||
| Improved myocardial function during exercise after successful percutaneous transluminal coronary angioplasty | Q70564665 | ||
| Status of the major epicardial coronary arteries 80 to 150 days after percutaneous transluminal coronary angioplasty. Analysis of 3 necropsy patients | Q72773601 | ||
| The mechanism of transluminal angioplasty: evidence for formation of aneurysms in experimental atherosclerosis | Q72794557 | ||
| Coronary artery spasm at the site of angioplasty in the first 2 months after successful percutaneous transluminal coronary angioplasty | Q72797563 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angioplasty | Q539795 |
| stenosis | Q2343082 | ||
| P304 | page(s) | 369-375 | |
| P577 | publication date | 1985-08-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty | |
| P478 | volume | 6 |
| Q36177187 | A Decoy Peptide Targeted to Protein Phosphatase 1 Attenuates Degradation of SERCA2a in Vascular Smooth Muscle Cells |
| Q37316783 | A bumpy and winding but right path to domestic drug-eluting coronary stents |
| Q73751978 | A high-precision, high-resolution and fast dosimetry system for beta sources applied in cardiovascular brachytherapy |
| Q37638598 | A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies |
| Q37994174 | A2 adenosine receptors and vascular pathologies |
| Q44591584 | Activation of mitogen-activated protein kinases during preparation of vein grafts and modulation by a synthetic inhibitor. |
| Q45014682 | Acute arteritis after coronary angioplasty |
| Q35681289 | Age-related neointimal hyperplasia is associated with monocyte infiltration after balloon angioplasty |
| Q67232044 | Angiographic morphology of recurrent stenoses after percutaneous transluminal coronary angioplasty: are lesions longer at restenosis? |
| Q37221177 | Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis model |
| Q33606997 | Antiplatelet therapy--Part II |
| Q64382508 | Antisense basic fibroblast growth factor gene transfer reduces neointimal thickening after arterial injury |
| Q91656952 | Apolipoprotein E deficient rats generated via zinc-finger nucleases exhibit pronounced in-stent restenosis |
| Q35829683 | Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice |
| Q24318760 | Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase |
| Q70036395 | Arterial changes after percutaneous transluminal coronary angioplasty: results at autopsy |
| Q58492272 | Arterial remodeling after experimental percutaneous injury is highly dependent on adventitial injury and histopathology |
| Q71653451 | Assessment of myointimal cellular kinetics in a model of angioplasty by means of proliferating cell nuclear antigen expression |
| Q33327084 | Atherosclerotic Rabbit Iliac Arteries: Comparison of Balloon Angioplasty and Laser-assisted Balloon Angioplasty |
| Q45199291 | Balloon angioplasty of aortocoronary saphenous vein bypass grafts: a histopathologic study of six grafts from five patients, with emphasis on restenosis and embolic complications |
| Q50010219 | Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta |
| Q31975358 | Brachytherapy with iridium-192 HDR to prevent from restenosis in peripheral arteries. An update |
| Q67954794 | Cell culture systems to study progression and inhibition of intimal proliferations |
| Q71724511 | Chronic arterial responses to stent implantation: a serial intravascular ultrasound analysis of Palmaz-Schatz stents in native coronary arteries |
| Q67740560 | Clinical angiographic and histologic correlates of eetasia after directional coronary atherectomy |
| Q67769924 | Comparative quantitative angiographic analysis of directional coronary atherectomy and balloon coronary angioplasty |
| Q35898414 | Complex carbohydrates in drug development |
| Q68809720 | Coronary angioplasty after intravenous streptokinase in acute myocardial infarction: influence of restenosis on clinical outcome and left ventricular function |
| Q70017380 | Coronary angioplasty and the persistent problem of restenosis |
| Q40485219 | Coronary histology after percutaneous transluminal coronary angioplasty. |
| Q41771381 | Coronary intimal proliferation after balloon injury and stenting in swing: An animal model of restenosis |
| Q72613868 | Cutting balloon coronary angioplasty--initial clinical experience |
| Q28277000 | Cutting balloon: A novel approach to percutaneous angioplasty |
| Q42010408 | Development of decellularized human umbilical arteries as small-diameter vascular grafts |
| Q74341070 | Different radiosensitivity of smooth muscle cells and endothelial cells in vitro as demonstrated by irradiation from a Re-188 filled balloon catheter |
| Q73286960 | Differential expression of nonmuscle myosin II isoforms in human atherosclerotic plaque |
| Q67903642 | Direct intraarterial wall injection of microparticles via a catheter: A potential drug delivery strategy following angioplasty |
| Q44963466 | Directional peripheral atherectomy: histopathologic aspects of a new interventional technique |
| Q43013493 | Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary intervention |
| Q74256685 | Dose distribution for a 32P-impregnated coronary stent: comparison of theoretical calculations and measurements with radiochromic film |
| Q73295912 | Dynamics of Vascular Remodeling: An Overview and Bibliography |
| Q71989771 | Effect of Nonanticoagulant Heparin (Astenose) on Restenosis after Balloon Angioplasty in the Atherosclerotic Rabbit |
| Q35048369 | Effect of a dual drug-coated stent with abciximab and alpha-lipoic Acid in a porcine coronary restenosis model |
| Q33584566 | Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury |
| Q43470332 | Effect of lovastatin on intimal hyperplasia after balloon angioplasty: A study in an atherosclerotic hypercholesterolemic rabbit |
| Q73202220 | Effect of transcatheter endovascular radiation with holmium-166 on neointimal formation after balloon injury in porcine coronary artery |
| Q78023011 | Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferation |
| Q33265693 | Effects of laser-generated tissue debris on aggregation of human platelets |
| Q35041906 | Effects of local delivery of trapidil on neointima formation in a rabbit angioplasty model |
| Q35343351 | Effects of ramiprilat-coated stents on neointimal hyperplasia, inflammation, and arterial healing in a porcine coronary restenosis model |
| Q46973492 | Effects of serum lipid levels on restenosis after coronary angioplasty |
| Q47306378 | Endoluminal local delivery of PCNA/cdc2 antisense oligonucleotides by porous balloon catheter does not affect neointima formation or vessel size in the pig coronary artery model of postangioplasty restenosis |
| Q72595198 | Endothelial cell seeding fails to attenuate intimal thickening in balloon-injured rabbit arteries |
| Q41837482 | Endothelial cell-restricted disruption of FoxM1 impairs endothelial repair following LPS-induced vascular injury |
| Q36689429 | Endothelial p110γPI3K Mediates Endothelial Regeneration and Vascular Repair After Inflammatory Vascular Injury |
| Q40835442 | Endovascular brachytherapy--treatment planning and radiation protection |
| Q51949210 | Evaluation of vascular injury following percutaneous transluminal coronary angioplasty: a comparison of the accuracy of two- and three-dimensional intracoronary ultrasound imaging |
| Q35728441 | Evidence supporting changes in Nogo-B levels as a marker of neointimal expansion but not adaptive arterial remodeling |
| Q36745602 | Experimental models of coronary artery restenosis |
| Q71956626 | Expression of IGF-I, IGF-I receptor and IGF binding proteins-1, -2, -3, -4 and -5 in human atherectomy specimens |
| Q35607475 | Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions |
| Q54036438 | Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty. |
| Q36810953 | Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial |
| Q37632037 | Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury |
| Q38532954 | Healing arterial ulcers: Endothelial lining regeneration upon vascular denudation injury |
| Q33613429 | High frequency rotational ablation: an alternative in treating coronary artery stenoses and occlusions |
| Q71244214 | High serum concentration of lipoprotein(a) is a risk factor for restenosis after percutaneous transluminal coronary angioplasty in Japanese patients with single-vessel disease |
| Q71858789 | Hyaluronan (HYAL-BV 5200) inhibits neo-intimal macrophage influx after balloon-catheter induced injury in the cholesterol-fed rabbit |
| Q24321634 | IRT-1, a novel interferon-gamma-responsive transcript encoding a growth-suppressing basic leucine zipper protein |
| Q72839754 | Iliac and femoropopliteal vascular occlusive disease treated with flexible tantalum stents |
| Q73025860 | Immunocytochemical determination of cell type and proliferation rate in human vein graft stenoses |
| Q36052078 | Impact of Insulin Resistance on Neointimal Tissue Proliferation after 2nd-Generation Drug-Eluting Stent Implantation |
| Q40961830 | Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis. |
| Q35769824 | In stent restenosis: bane of the stent era. |
| Q45876633 | In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI. |
| Q44792748 | Inducible expression of the signal transduction protein 14-3-3gamma in injured arteries and stimulated human vascular smooth muscle cells |
| Q43584690 | Inhibition of carotid artery neointimal formation with intravenous microbubbles. |
| Q64963376 | Inhibition of intimal hyperplasia in balloon injured arteries with adjunctive phthalocyanine sensitised photodynamic therapy. |
| Q28577608 | Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides |
| Q77565074 | Intra-arterial photodynamic therapy using 5-ALA in a swine model |
| Q71807526 | Intracoronary Low-Dose β-Irradiation Inhibits Neointima Formation After Coronary Artery Balloon Injury in the Swine Restenosis Model |
| Q71875571 | Intracoronary irradiation: dose response for the prevention of restenosis in swine |
| Q73728151 | Intracoronary radiation decreases the second phase of intimal hyperplasia in a repeat balloon angioplasty model of restenosis |
| Q77860745 | Intravascular ultrasound assessment of the relation between early and late changes in arterial area and neointimal hyperplasia after percutaneous transluminal coronary angioplasty and directional coronary atherectomy |
| Q36801786 | Intravascular ultrasound imaging of peripheral arteries as an adjunct to balloon angioplasty and atherectomy |
| Q35298012 | Laser ablation and the need for intra-arterial imaging |
| Q34133379 | Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty |
| Q39481442 | Medical approaches to prevention of restenosis after coronary angioplasty |
| Q34138775 | Modulation by beta-aminopropionitrile of vessel luminal narrowing and structural abnormalities in arterial wall collagen in a rabbit model of conventional balloon angioplasty versus laser balloon angioplasty |
| Q30394513 | Nanostructured ultra-thin patches for ultrasound-modulated delivery of anti-restenotic drug |
| Q27005674 | Novel paradigms for dialysis vascular access: downstream vascular biology--is there a final common pathway? |
| Q51489564 | Patency of experimental microvascular autografts of the common carotid artery after balloon dilatation in rats: a technical note and preliminary results. |
| Q34118660 | Pathological changes induced by repeated percutaneous transluminal coronary angioplasty |
| Q36491268 | Peptide inhibition of myointimal proliferation by angiopeptin, a somatostatin analogue |
| Q70021332 | Percutaneous coronary angioplasty: technique, indications, and results |
| Q30467107 | Peripheral angioplasty balloon technology |
| Q40836528 | Pharmacological approaches to the prevention of restenosis after coronary angioplasty |
| Q40490671 | Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II). |
| Q73533669 | Placement of endothelial cells on the luminal surface of denuded arteries in vitro and in vivo |
| Q60728360 | Platelet deposition after angioplasty is abolished by restoration of the endothelial cell monolayer |
| Q68125873 | Platelets and antiplatelet therapy in ischemic heart disease |
| Q35643826 | Potential of combined thromboxane A2 and serotonin antagonists to prevent the development of unstable angina and acute myocardial infarction. |
| Q36564389 | Potential roles of osteopontin and alphaVbeta3 integrin in the development of coronary artery restenosis after angioplasty |
| Q77983394 | Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators |
| Q44053091 | Preparation and evaluation of [166Ho] holmium-dimethyl diethylenetriaminepentaaceticacid (DMDTPA) as potential radiopharmaceutical for endovascular radiation therapy (EVRT). |
| Q40897587 | Prevention of restenosis future directions |
| Q44963784 | Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy: a histopathologic study |
| Q37318071 | Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit |
| Q68352602 | Production of Platelet-Derived Growth Factor–like Mitogen by Smooth-Muscle Cells from Human Atheroma |
| Q44638607 | Profound negative regulatory effects by resveratrol on vascular smooth muscle cells: a role of p53–p21WAF1/CIP1 pathway |
| Q33545073 | Radiation therapy to prevent coronary artery restenosis |
| Q69371734 | Randomised trial of fish oil for prevention of restenosis after coronary angioplasty |
| Q41627075 | Regional remodeling of atherosclerotic arteries: a major determinant of clinical manifestations of disease |
| Q77107555 | Remodeling after directional coronary atherectomy (with and without adjunct percutaneous transluminal coronary angioplasty): a serial angiographic and intravascular ultrasound analysis from the Optimal Atherectomy Restenosis Study |
| Q34016500 | Restenosis after angioplasty |
| Q73017845 | Restenosis after coronary angioplasty |
| Q38044666 | Restenosis after coronary angioplasty: new standards for clinical studies |
| Q70053048 | Restenosis after percutaneous transluminal coronary angioplasty |
| Q68190785 | Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients |
| Q70059126 | Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients |
| Q81665515 | Restenosis after transluminal angioplasty for atherosclerotic vertebral and subclavian artery stenosis |
| Q37527806 | Restenosis following coronary angioplasty |
| Q38140546 | Restenosis following coronary angioplasty |
| Q68587516 | Restenosis following coronary angioplasty |
| Q34395052 | Restenosis following coronary angioplasty: current status |
| Q34728035 | Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features |
| Q74611649 | Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: effects on neointimal hyperplasia and vascular remodeling |
| Q73842714 | Samarium-153 for intravascular irradiation therapy with liquid-filled balloons to prevent restenosis: acute and long-term results in a hypercholesterolemic rabbit restenosis model |
| Q52229319 | Serial volumetric (three-dimensional) intravascular ultrasound analysis of restenosis after directional coronary atherectomy. |
| Q36885835 | Short wave ultraviolet laser energy in porcine coronary arteries: medial cell death and neointimal formation |
| Q46735847 | Spontaneous regression of restenosis: An angiographic study |
| Q43169653 | Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth |
| Q35767647 | Sustained inhibition of intimal thickening. In vitro and in vivo effects of polymeric beta-cyclodextrin sulfate |
| Q49378980 | Synthetic E-selectin prevents postoperative vascular restenosis by inhibiting nuclear factor κB in rats |
| Q34197488 | The American Brachytherapy Society perspective on intravascular brachytherapy |
| Q37390795 | The comparative efficacy of percutaneous and surgical coronary revascularization in 2009: a review |
| Q34054435 | The comparative pathobiology of atherosclerosis and restenosis |
| Q34746674 | The development of interventional cardiology |
| Q77811664 | The effect of external electron beam on neointima in rat carotid artery injury model |
| Q57797673 | The effects of stenting on coronary endothelium from a molecular biological view: Time for improvement? |
| Q40356371 | The inhibition of neutrophil-endothelial cell adhesion by hyaluronan independent of CD44. |
| Q33890371 | The mechanisms of coronary restenosis: insights from experimental models |
| Q68928480 | The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty |
| Q70013081 | The spectrum of pathology associated with percutaneous transluminal coronary angioplasty during acute myocardial infarction |
| Q73560116 | Thrombus organization plays no major role in late neointimal formation after angioplasty in porcine coronary arteries |
| Q59384963 | Timecourse of fibrin deposition and removal after arterial injury |
| Q36581185 | Tissue Kallikrein Prevents Restenosis After Stenting of Severe Atherosclerotic Stenosis of the Middle Cerebral Artery: A Randomized Controlled Trial |
| Q73566039 | Tolerance of normal rabbit femoral arteries to single high dose external beam irradiation |
| Q46055123 | Transluminal atherectomy for occlusive peripheral vascular disease |
| Q71987300 | Ultrastructural characteristics of cellular reaction after experimentally induced lesions in the arterial vessel |
| Q74614625 | Use of endothelial cells containing superparamagnetic microspheres to improve endothelial cell delivery to arterial surfaces after angioplasty |
| Q40827380 | Using CCM and DHPLC to detect mutations in the glucocorticoid receptor in atherosclerosis: a comparison |
| Q41139306 | Vascular Protection with Cilazapril |
| Q33942624 | Vascular radiation therapy to reduce coronary artery restenosis. |
| Q41198945 | Very early prediction of restenosis after successful coronary angioplasty: anatomic and functional assessment |
| Q68190789 | What does pathology teach us about recurrent stenosis after coronary angioplasty? |
| Q74387892 | [Endovascular Ir-192 HDR brachytherapy for avoidance of intimal hyperplasia in peripheral vessels after PTA and stent implantation. A 6-year experience] |
Search more.